Norges Bank’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-800,173
Closed -$22.9M 2150
2018
Q4
$22.9M Hold
800,173
0.01% 1309
2018
Q3
$22.3M Hold
800,173
0.01% 1457
2018
Q2
$22.3M Sell
800,173
-43,204
-5% -$1.16M 0.01% 1442
2018
Q1
$21M Sell
843,377
-1,696
-0.2% -$41.3K 0.01% 1401
2017
Q4
$20.5M Buy
845,073
+84,305
+11% +$2.22M 0.01% 1450
2017
Q3
$21M Buy
760,768
+372,456
+96% +$9.93M 0.01% 1408
2017
Q2
$9.73M Buy
388,312
+17,844
+5% +$442K ﹤0.01% 1746
2017
Q1
$9.94M Sell
370,468
-81,290
-18% -$2.25M ﹤0.01% 1743
2016
Q4
$11.8M Sell
451,758
-35,600
-7% -$880K 0.01% 1616
2016
Q3
$11.6M Sell
487,358
-45,900
-9% -$1.07M 0.01% 1565
2016
Q2
$11.6M Buy
533,258
+233,299
+78% +$4.16M 0.01% 1530
2016
Q1
$4.5M Buy
299,959
+222,641
+288% +$3.73M ﹤0.01% 1871
2015
Q4
$1.69M Buy
77,318
+11,600
+18% +$216K ﹤0.01% 2053
2015
Q3
$1.04M Hold
65,718
﹤0.01% 2107
2015
Q2
$939K Sell
65,718
-63,372
-49% -$1.07M ﹤0.01% 2133
2015
Q1
$2.23M Sell
129,090
-24,814
-16% -$438K ﹤0.01% 2054
2014
Q4
$2.76M Hold
153,904
﹤0.01% 2050
2014
Q3
$2.02M Sell
153,904
-153,904
-50% -$2.07M ﹤0.01% 2095
2014
Q2
$4.42M Sell
307,808
-74,683
-20% -$975K ﹤0.01% 2086
2014
Q1
$4.87M Sell
382,491
-1,043,259
-73% -$13.6M ﹤0.01% 1897
2013
Q4
$14.3M Hold
1,425,750
0.01% 1351
2013
Q3
$18.8M Buy
1,425,750
+1,081,848
+315% +$14.2M 0.01% 1123
2013
Q2
$4.91M Buy
+343,902
New +$4.32M ﹤0.01% 1849

Other funds holding NXTM

Norges Bank's NXTM Position: Q1 2019 in Review

Norges Bank sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 800,173 shares — an estimated $22.9M sold.

Norges Bank first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $22.9M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Norges Bank reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Norges Bank sold 800,173 NxStage Medical Inc. shares in Q1 2019, an estimated $22.9M.
  • Norges Bank first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Norges Bank's NxStage Medical Inc. position peaked at $22.9M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Norges Bank's 13F filing for Q1 2019, filed 9 May 2019.